chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lasted from 11pm 05/10/21 (day of shot ) until 8am  05/12/21.    Horrific headache close to migraine, complete body aches, like being ran over by Mack truck, no fever, nauseous and had trouble with appetite, not wanting to eat for fear I would be sick. On morning of 05:112/21 I felt much more normal
Left arm: bruises around site of injection and throbbing pain when left arm is used or has pressure on it.
Information has been received from a physician concerning an unknown number of patients who on unknown dates were orally vaccinated with 2 mL of the first dose of ROTATEQ (Lot # and expiration not reported) at 14 weeks of age. No adverse effects were reported. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
an 8 year old patient received Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis.   On 11-APR-2023, the patient received Kinrix. On 11-APR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: an 8 year old patient received Kinrix). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-APR-2023 The reporter declined to provide patient's initials. The reporter stated that 8 years old patient received Kinrix. The Vaccine administration facility was the same as Primary Reporter. The reporter consented to follow up via postal. The reporter stated that 8 years old patient received Kinrix, which led to inappropriate age at vaccine administration.
Pain on right side of chest, more intense when breathing in; Headache; Intense pain on whole body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Intense pain on whole body), CHEST PAIN (Pain on right side of chest, more intense when breathing in) and HEADACHE (Headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006BZ1A and 030AZ1A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PAIN (Intense pain on whole body) and HEADACHE (Headache). On 05-Apr-2021, the patient experienced CHEST PAIN (Pain on right side of chest, more intense when breathing in). The patient was treated with IBUPROFEN at a dose of 600 mg. At the time of the report, PAIN (Intense pain on whole body), CHEST PAIN (Pain on right side of chest, more intense when breathing in) and HEADACHE (Headache) was resolving. Not Provided
No adverse effect during the 15 minutes after administration of vaccine   patient expired on 9/23/21 reported by facility
After my vaccine, the left half of my face went numb, hot burning sensation. It has not improved. I still have a numb, coolness to my face. I have an upcoming appointment with a neurologist and do an MRI.  I have no pain, just a weird feeling on my face.  I have no facial paralysis.
This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (the arm hurts a little), anosmia (lost the sense of smell), nasal congestion (extremely congested) and fatigue (feels really exhausted) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch no. 039K202A) for COVID-19 immunization. Concurrent medical conditions included asthma. On Jan 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced vaccination site pain (the arm hurts a little) and fatigue (feels really exhausted). On Jan 22, 2021, patient experienced anosmia (lost the sense of smell) and nasal congestion (extremely congested). At the time of the report, vaccination site pain (the arm hurts a little), anosmia (lost the sense of smell),  nasal congestion (extremely congested) and fatigue (feels really exhausted) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Products known to have been used by the patient, within two weeks prior to the event, included asthma inhaler. Treatment information not provided.
Weakness Fever Nausea Shivers Soreness, swelling and warm to the touch at injection site
I had chills and body ache. I had a sore arm. I had very bad migraine headache with an aura and aphasia. These lasted for about 24 hours. I talked to my doctor about this. He said I need to make an appointment with the neurologist. I have an appointment in Jan.
Right posterior thigh with 3cm area erythema with very mild induration, no warmth, not tender to palpation, skin otherwise without rash or lesion except for eczema to arms and legs bilaterally.
was administered the separate Hib component of the Pentacel vaccine reconstituted with an unknown diluent, without the DTaP-IPV component with no AE; was administered the separate Hib component of the Pentacel vaccine reconstituted with an unknown diluent, without the DTaP-IPV component with no AE; Initial information received on 29-Dec-2022 regarding an unsolicited non-valid non-serious case received from a other health professional.  This case involves a patient of unknown age and gender who was administered the separate hib component of the diphtheria/tetanus/5 hybrid AC pertussis /IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel] reconstituted with an unknown diluent, without the dtap-ipv component with no adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s), vaccination(s) and family history were not provided.  On an unknown date, the patient was administered an unknown dose of suspect diphtheria/tetanus/5 hybrid AC pertussis /IPV(MRC5)/HIB(PRP/T) vaccine, suspension for injection (strength - unknown, frequency - once, lot - UJ678AAA and expiry date -09-Sep-2023) via unknown route in unknown administration site for immunization.  On an unknown date the patient was administered the separate hib component of the pentacel vaccine reconstituted with an unknown diluent, without the dtap-ipv component with no adverse event (product preparation error) (single component of a two-component product administered) (unknown latency)   Reportedly, HCP stated that they discovered a box of Pentacel that still had the DTaP-IPV component, but the Hib component had been removed and administered to a patient. HCP stated that they do not know the date this happened, and they do not know which child was administered the separate Hib component of the Pentacel vaccine, without the DTaP-IPV component. They also do not know with what type of diluent the Hib component of the Pentacel vaccine was reconstituted with, prior to administration. HCP stated that they do not know which child received the Hib component of the Pentacel vaccine, but they have narrowed it down to five children, any one of whom may be the one that received the Hib component of the Pentacel vaccine, mixed with an unknown diluent. These five candidates range in age from 6 months old to 4 years old.   Action taken was not applicable.  At time of reporting, the outcome was Unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
I just didn't feel, my husband had a cough, since my throat started feeling sore, I took a home COVID-19 test, it came back positive. I made my husband take a home test also. I called my doctor to discuss my positive test and symptoms. I was given a prescription of Paxlovid, Albuterol Inhaler, Benzonatate, Ibuprofen that I was able to start that night. I took the whole five-day regimen; it took another three or four days after that before I started feeling better.
Information has been received from a consumer concerning his wife with no pertinent medical history who in the beginning of December 2009 was vaccinated with a first 0.5 ml dose of GARDASIL. There was no concomitant medication. In the beginning of December 2009 the patient experienced injection site pain for 3 to 5 days after being vaccinated. Subsequently, the patient recovered from injection site pain. No labs were performed. The patient did not seek any medical attention. Additional information has been requested.
Initial report received from a physician on 31 Dec 2009: This patient was received FLUVIRIN on an unknown date. The patient had macular papular rash in Oct 2004. The patient hadn't had an influenza vaccination since that time. MD was attempting to rule out possibilities. Explained to MD that FLUVIRIN was not released on the market that year. The outcome of the event was not reported.
Moderna COVID-19 Vaccine EUA.  Stomach pain, cramping, discomfort and diarrhea for over 5 days.  Over the counter medications have helped, but not resolved the issue.
Extreme allergy reaction, hives in mouth and lips, eyes and nose itchy I want to tear my face off. Lips and lower face are becoming more swollen. I have no access to Health insurance so I will take a shower and some Benadryl, my only attainable recourse at this time.
TMD plus she is having some skin issue that the doctor thought be herpes; TMD plus she is having some skin issue that the doctor thought be herpes; TMD plus she is having some skin issue that the doctor thought be herpes; complaints of acid reflux; This is a spontaneous report from a contactable consumer. A 77-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 02Oct2021 09:30 (Batch/Lot Number: FF8839) at the age of 77 years old as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunisation. Medical history was none. (Patient's Medical History (including any illness at time of vaccination): none). There were no concomitant medications. There were no prior vaccinations within 4 weeks. On an unspecified date in 2021, the patient received flu vaccine few days prior (as reported). Other historical vaccines included BNT162B2 received by the patient on 21Jan2021 (Batch/Lot Number: EL9261) as dose 1, single, and BNT162B2 on 11Feb2021 (Batch/Lot Number: EM9809) as dose 2, single; both at the age of 76 years for COVID-19 immunisation. The patient received the Pfizer Covid-19 booster dose on 02Oct2021 and was prescribed acyclovir and prednisone on 08Oct2021. The patient stated that she started taking the prednisone three days after the booster dose of the Pfizer COVID-19 vaccine and only took two prednisone pills over two days and could not take anymore due to complaints of acid reflux. She asked if prednisone can interfere with the Pfizer COVID-19 vaccine. She was given some short-term medication. They were called acyclovir and prednisone. They were prescribed for TMD (Temporomandibular joint disorder) plus she had some skin issue that the doctor thought to be herpes. She just wanted to make sure they wouldn't compromise the vaccine. She went to the doctor and got the diagnosis of TMD and possible herpes on 08Oct2021, that is when the acyclovir was started. She didn't start the prednisone for 3 days and only took 2-3 pills and stopped, she couldn't handle it. She confirmed she was not taking the Prednisone but was taking the acyclovir. She thought it was probably okay, but she wanted to make sure, she didn't realize they were both immune suppressing. She remarks that she was probably worried about nothing especially since she hasn't taken very many; the most of the Prednisone used were 3 tablets, though this was not how the doctor wanted her to take it. She was supposed to take 4 the first day and so on. Therapeutic measures were taken as a result of events: "TMD plus she had some skin issue that the doctor thought be herpes" and these events resulted in Physician office visit. Outcome of all the events was unknown.   Follow-up attempts are completed. No further information is expected.
Hives beginning on right foot several hours after receiving the vaccine; eventually affecting areas all over the body with large patches of hives. As of today, 04/14/2021, hives are still present though they seem to finally be improving/occurring less (I have never had hives or an allergic type of reaction to anything previously to anything that I know of).
A 15month old male was given an expired dose of DTAP . DTAP expired on 09/16/23, and it was given on 9/18/23.  There were no adverse affects following in clinic. The parent was notified, and followed up with 3 days later by phone. She did not report any health concerns about the patient.  Per CDC guidelines,  I recommended that MOP return to have this shot given again.      Vaccine Type: Infanrix-DTaP    Mfr: GlaxoSmithKline    Dose: 0.5 ml    Route: IM
Systemic: Fainting / Unresponsive-Severe, Systemic: Fainted, recovered within seconds.  Gave water and monitored-Severe
From patient comments "The site has gotten red, swollen, tender. It's also very itchy. She's tried some over-the-counter BENADRYL which hasn't helped much. She has never had a local reaction to a shot which she did pass out once when she was a child for an immunization. She denies any problems breathing and then she's aggravated from the wildfire smoke. No throat or mouth swelling." Physician exam: Skin warm and dry. Left upper arm over the deltoid there is very induration and erythema approximately 2 inches around surrounding the injection site. It is tender to palpation. It's tender to palpation inferior to this. There is no streaking. It is warm to the touch but not fluctuant. No lip or facial swelling.
the site of injection started to hurt; felt exhausted the rest of the day; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient received bnt162b2 (BNT162B2), administration date 22Nov2021 (Batch/Lot number: unknown) at the age of 40 years as dose 3(booster), single for covid-19 immunization. The patient's relevant medical history was not reported. Concomitant medication(s) included: ANTACID [ALUMINIUM HYDROXIDE GEL;MAGNESIUM HYDROXIDE;SIMETICONE]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 IMMUNIZATION; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 22Nov2021, outcome "unknown", described as "the site of injection started to hurt"; FATIGUE (non-serious) with onset 22Nov2021, outcome "unknown", described as "felt exhausted the rest of the day"; HEADACHE (non-serious) with onset 22Nov2021, outcome "unknown", described as "headache".  Additional Information: Concomitant therapy included vitamins.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
NOT EATING; LETHARGIC; HIGH FEVER; This spontaneous report received from a parent concerned an 18 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 08-APR-2021, the subject experienced high fever. On 08-APR-2021, the subject experienced lethargic. On 08-APR-2021, the subject experienced not eating. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lethargic, high fever and not eating was not reported. This report was non-serious.
The day after she received her vaccine she noticed a blister approximately three inches posterior to the site of the vaccine injection.  The blister popped and oozed serosanguinous fluid.  She reported to the occupational health clinic on 11/11/19.  Blistered area has crusted over, no current signs of drainage, no cellulitis noticed around blister.   She also reports headache, mild fever and myalgia on 11/6/19 which resolved within 24 hours.
Severe, uncontrollable chills, extreme nausea, vomited twice, headache, fever that reached 101.9 at 2:00 am.
Ringing in ear - at first I interpreted this as a 'rush' and had mild euphoric sensation.  The ringing began and it hasn't quit, although it varies in loudness
Pt recvd Hep B vax & devel a rash; pt ws referred to an allergist for treatment;
EXPERIENCING SIDE EFFECTS; This spontaneous report received from a patient via a company representative concerned multiple patients. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced experiencing side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of experiencing side effects was not reported. This report was non-serious. This case, from the same reporter is linked to 20210318906.
Numbness of lips and tongue, paresthesias in upper extremity, nausea; LIP, and AMR gave Zofran and breathing technique - reaction resolved.  Extended monitoring was provided.
I developed a bright red rash on my right arm a week after I received my first dose. It mostly resolved within 48 hours.
increased cough, difficulty breathing, anaphylaxis; received IM EpiPen, IM Benadryl, and IV Solumedrol 125mg Symptoms improved; did not need repeat Epi dosing. did not receive Famotidine because has documented allergy to Ranitidine.
swelling rash and swollen distal cervical/supraclavicular lymphadenopathy and pain 24 hr after and then lymph node presented about 72 hr after
pt recvd vax & exp severe redness & soreness @ the inj site; pt recvd no other vax on the same date; pt was treated w/DPh; other pts recvd the vax from the same vial & did not have reacts;
chronic fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (chronic fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (chronic fatigue). At the time of the report, FATIGUE (chronic fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Moderna Covid 19 Vaccine  EUA On 8th day after injection observed bruise at injection site, redness and slight swelling on upper arm. A bit warm to the touch and some itching.
Burning gastro intestinal pain, similar to the inflammation caused by a metal allergy (some earring metals cause my ears to inflame).
Hepatitis B Surface Antigen in Study. Post administration, exp myalgia of back, neck. Inc in severity on 7/18/99 with muscle weakness. Sharp upper back pain. Withdrew from study.
Pt recvd vax 26SEP92 & shortly following 1st vax devel coughing, sneezing, sinus infection, achiness, & flu-like sx;
04.00 start of Dizziness, Fatigue, Fever for 2 days
Generalized tonic-clonic seizure; duration approx 2 minutes, associated with headache. Two episodes of emesis, abdominal pain. Evaluated in ER and by MD in office; referred to neurologist.
Sudden onset of dizziness, lightheaded ness, nausea, swollen glands at cervical region, fatigue, body aches; lasting 5 hours. Ongoing gland swelling with meals.
Redness, swelling, warmth at injection site, area ~2 in by 4 in on 1/8/21 and was about half the width and length on 1/7/21.
Pt (adult age 19) was administered her first dose of the Pfizer Covid 19 vaccine at approx 8:30 AM on Friday 7/9/21. Pt did not appear to be in any distress. Upon completion of the vaccine administration, the pt sat in recovery chair with mother. After about 2 min, pt was talking to mother and passed out. Mother revived her by toughing her. She did not fall. the administering pharmacist was notiied and went out to the pt. Pt put head between knees to get blood flow to head and took deep slow breaths. She was given water. CSM, also came over and they both calmed her down and had her move her arms to help with her circulation due to complaint of arms feeling funny. Pt said she had worked the night shift the previous night & had not slept or ate so she got her a bottle of orange juice to sip on. Once pt sat for about 30 mins, she felt better and her mother escorted her out.
She was already tired going into the vaccination because she had gone down stairs, which was hard for her. She had to wait for about an hour after appointment in a noisy environment. The next morning she was too tired to get out of bed, which was unusual, but she was eating normally. She has two shakes and two meals a day. She went several days of just completely exhausted, and did have some diarrhea. I requested the doctor test her Iron and her doctor also completed a  CBC panel, and that was okay. Then she developed a UTI. Once she recovered from that she started regaining her strength again and then developed an upper respiratory infection. I did test her for COVID-19 but she was negative. She became very congested and was exhausted again, and developed a wet, coughing, rattle, but she couldn't fully cough because she was so weak. I'm not able to determine if she experienced any headaches but I give her Tylenol before bed just in case, but she has kept her appetite, is resting more. She started taking the DM max that has a cough suppressant and expectorant, and Vick's Vapo rub as suggested by her doctor via email. I've also added a humidifier and that is making a marked difference. I have a pulse oximeter that I use to check her and a few days her pulse was a little low. She normally stays around 95/96, but it dipped to 93/94. Her temperature has never reached above 99, I am very careful and never let her get over 100.
Information has been received from a physician concerning a pt who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 647271/1138N).  Subsequently the pt developed soreness after vaccination. The pt's outcome was unknown. There was no product quality complaint involved. The reporter also indicated that another pt (WAES # 0405USA00013) had a similar experience following exposure to pneumococcal 23v polysaccharide vaccine. Additional information has been requested.
On September 15, 2022 I was vaccinated with Moderna and i experienced abdominal pain, chest tightness, fever,  chills, sweating, really bad headaches, dizziness, gassy, skin was fragile to touch, muscle aches, and arm soreness.
Being treated with methotrexate injections and no relief for 1 year. Pain is at a 9/10 daily and has spread to hips and spine.